Paclitaxel from primary taxanes: a perspective on creative invention in organozirconium chemistry

J Org Chem. 2007 May 25;72(11):3981-7. doi: 10.1021/jo070129s. Epub 2007 Mar 24.

Abstract

In this Perspective, which describes the achievements recognized by the 2007 ACS Award for Creative Invention, we discuss the discovery of a new synthetic reaction and its translation into a substantially improved method for manufacturing a major pharmaceutical product--the blockbuster anticancer drug, paclitaxel. The role of creativity in the discovery and invention processes is also discussed. As is often the case, chance discovery and serendipitous findings played a role in the evolution of this work. Translation of the basic research into a commercially viable paclitaxel semisynthesis is also described. The final manufacturing process illustrates the enormous impact that the globalization of markets has had on chemical and pharmaceutical manufacturing.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemistry*
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Organometallic Compounds / chemistry*
  • Paclitaxel / chemistry*
  • Paclitaxel / pharmacology
  • Taxoids / chemistry*
  • Zirconium / chemistry*

Substances

  • Antineoplastic Agents, Phytogenic
  • Organometallic Compounds
  • Taxoids
  • Zirconium
  • Paclitaxel